HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--May 2, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX - News) is pleased to announce that positive results from successful clinical studies of the Company’s AlzheimAlert (TM) test will be presented at the upcoming Annual Meeting of the American Psychiatric Association to be held in Toronto from May 20 to 25, 2006. Study data and findings will be presented by first author Dr. Ira Goodman of the Orlando Regional Healthcare System. Dr. Goodman was a principal investigator in the reported studies. Recognized worldwide, the American Psychiatric Association has over 35,000 U.S. and international member physicians.
